Torrent Pharma Q4 net may jump 145%, margins likely at 30%

Net profit of Torrent Pharma is likely to jump by a whopping 145 percent at Rs 319 crore in January-March quarter from Rs 130 crore in corresponding quarter last fiscal. According to a CNBC-TV18 poll, the pharma company's net revenue may also increase 28 percent to Rs to Rs 1477.2 crore compared to Rs 1154 crore in year-ago period. 

During the period, its EBITDA may grow 174 percent at  Rs 444 crore versus Rs 162 crore while operating profit margins may stand at 30.1 percent against 14 percent year-on-year.

Watch out for #Over 25 percent increase in sales likely #Revenue growth to be led by sales of mental health drug is Abilify generic #However, the contribution from Abilify generic to USD 25-27 million#India business likely to witness over 15 percent growth YoY with integration of Elder’s portfolio #EBITDA and margins to double due to contribution of Abilify generic #Profit to grow inline with operational performance